Overview: BK Virus Quantitative PCR TestIntroduction: The BK Virus Quantitative PCR Test measures BK virus levels to monitor kidney transplant complications, causing kidney dysfunction or urinary issues. Aligned with 2023 AST guidelines, it uses PCR for high sensitivity, aiding in infectious disease screening. This test is critical for guiding treatment adjustments, monitoring viral load, and improving outcomes in virology for transplant patients.
Other Names: BK Virus Quant PCR Assay, Transplant Viral Monitoring Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: BK virus monitoring began in the 2000s with quantitative PCR. By the 2010s, real-time PCR improved sensitivity for transplant management.
Purpose: Monitors BK virus levels, guides treatment adjustments, and tracks infection in transplant patients with kidney dysfunction or urinary issues.
Test Parameters: 1. BK Virus DNA
Pretest Condition: No fasting required. Collect swab, sputum, body fluid, plasma, urine, or saliva at any time. Report transplant history or symptoms like urinary issues.
Specimen: 1-2 swabs (sterile swab/transport medium), 5-10 mL sputum (sterile container), 5-10 mL body fluid (sterile container), 2-4 mL plasma (EDTA), 5-20 mL urine (sterile container), or 1-2 mL saliva (sterile container). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document transplant history, kidney dysfunction, or urinary symptoms. Include current medications, especially immunosuppressants.
Consent: Written consent required, detailing the tests purpose, implications for treatment monitoring, and potential need for antiviral therapy.
Procedural Considerations: Uses real-time PCR to quantify BK virus DNA. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Improper storage or delayed transport can degrade DNA. Immunosuppressants may affect viral load detection.
Clinical Significance: Elevated BK virus levels indicate active infection, prompting antiviral therapy or immunosuppression reduction. Low levels suggest controlled infection.
Specialist Consultation: Consult a nephrologist for result interpretation. An infectious disease specialist referral is advised for treatment planning.
Additional Supporting Tests: BK virus qualitative PCR, kidney function tests, or renal biopsy to assess infection or kidney damage.
Test Limitations: False negatives may occur with low viral loads. Results require clinical correlation with transplant history.
References: AST Transplant Guidelines, 2023; American Journal of Transplantation, Hirsch HH, 2022.
